€43.18
1.98%
Xetra, Aug 22, 05:35 pm CET
ISIN
DE0005313704
Symbol
AFX
Index

Carl Zeiss Meditec Stock price

€43.18
-7.17 14.24% 1M
-11.62 21.20% 6M
-2.34 5.14% YTD
-19.37 30.97% 1Y
-85.92 66.55% 3Y
-50.32 53.82% 5Y
+20.45 89.97% 10Y
+32.28 296.18% 20Y
Xetra, Closing price Fri, Aug 22 2025
+0.84 1.98%
ISIN
DE0005313704
Symbol
AFX
Index

Key metrics

Basic
Market capitalization
€3.8b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
25.6 | 22.6
P/S
1.7 | 1.7
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
€0.60
Yield 1Y | 5Y
1.4% | 0.7%
Growth 1Y | 5Y
-45.5% | -1.6%
Payout 1Y | 3Y
29.9% | 32.8%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€2.2b | €2.2b
EBITDA
- | €395.5m
EBIT
€184.9m | €257.2m
Net Income
€150.1m | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
5.5% | 8.0%
EBITDA
- | 20.9%
EBIT
-30.4% | 32.3%
Net Income
-26.1% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
52.0%
EBITDA
- | 17.7%
EBIT
8.5%
Net
6.9% | -
Free Cash Flow
-
Financial Health
Equity Ratio
60.2%
Return on Equity
8.8%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
€1.7
FCF per Share
-
Short interest
-
Employees
6k
Rev per Employee
€360.0k
Show more

Is Carl Zeiss Meditec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Carl Zeiss Meditec Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Carl Zeiss Meditec forecast:

10x Buy
45%
11x Hold
50%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Carl Zeiss Meditec forecast:

Buy
45%
Hold
50%
Sell
5%

Financial data from Carl Zeiss Meditec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,180 2,180
5% 5%
100%
- Direct Costs 1,046 1,046
13% 13%
48%
1,134 1,134
0% 0%
52%
- Selling and Administrative Expenses 630 630
18% 18%
29%
- Research and Development Expense 319 319
9% 9%
15%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 185 185
30% 30%
8%
Net Profit 150 150
26% 26%
7%

In millions EUR.

Don't miss a Thing! We will send you all news about Carl Zeiss Meditec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Carl Zeiss Meditec Stock News

AD HOC NEWS
4 days ago
Die Privatbank Berenberg hat das Kursziel für Carl Zeiss Meditec DE0005313704 von 65 auf 47 Euro gesenkt, aber die Einstufung auf "Hold" belassen.
AD HOC NEWS
4 days ago
Die kanadische Bank RBC hat das Kursziel für Carl Zeiss Meditec DE0005313704 von 60 auf 47 Euro gesenkt, aber die Einstufung auf "Sector Perform" belassen.
AD HOC NEWS
13 days ago
Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec DE0005313704 anlässlich der jüngst veröffentlichten Geschäftszahlen von 55 auf 45 Euro gesenkt, die Einstufung aber auf "Hold" belassen.
More Carl Zeiss Meditec News

Company Profile

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on October 4, 1995 and is headquartered in Jena, Germany.

Head office Germany
CEO Markus Weber
Employees 5,730
Founded 1995
Website www.zeiss.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today